1887
Editorial Open Access
Like 0
Preview this article:
Zoom in
Zoomout

Note from the editors: World Tuberculosis Day 2018 and Special issue–Screening and prevention of infectious diseases in newly arrived migrants in Europe, Page 1 of 1

| /docserver/preview/fulltext/eurosurveillance/23/12/eurosurv-23-12-1-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2018.23.12.180322-1
2018-03-22
2018-08-17
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2018.23.12.180322-1
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/23/12/eurosurv-23-12-1.html?itemId=/content/10.2807/1560-7917.ES.2018.23.12.180322-1&mimeType=html&fmt=ahah

References

  1. European Centre for Disease Prevention and Control (ECDC)/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2018 – 2016 data. Stockholm: ECDC; 2018. Available from: https://ecdc.europa.eu/sites/portal/files/documents/ecdc-tuberculosis-surveillance-monitoring-Europe-2018-19mar2018.pdf
  2. United Nations (UN). Transforming our World: The 2030 Agenda for Sustainable Development. Goal 3. New York: UN; 2015. Available from: https://sustainabledevelopment.un.org/post2015/transformingourworld/publication
  3. World Health Organization (WHO) Regional Office for Europe. Roadmap to implement the tuberculosis action plan for the WHO European Region 2016–2020. Towards ending tuberculosis and multidrug-resistant tuberculosis. Copenhagen: WHO; 2016. Available from: http://www.euro.who.int/__data/assets/pdf_file/0020/318233/50148-WHO-TB-Plan_May17_web.pdf?ua=1
  4. Tagliani E, Cirillo DM, Ködmön C, van der Werf MJEUSeqMyTB Consortium. EUSeqMyTB to set standards and build capacity for whole genome sequencing for tuberculosis in the EU. Lancet Infect Dis. 2018;18(4):377.  https://doi.org/10.1016/S1473-3099(18)30132-4 
  5. Eurosurveillance editorial team. Call for papers for a special issue on screening and prevention of communicable diseases in newly arrived migrants in Europe. Euro Surveill. 2017;22(13):30500. https://doi.org/10.2807/1560-7917.ES.2017.22.13.30500
  6. Kuehne A, Hauer B, Brodhun B, Haas W, Fiebig L. Find and treat or find and lose? Tuberculosis treatment outcomes among screened newly arrived asylum seekers in Germany 2002 to 2014. Euro Surveill. 2018;23(11):17-00042.  https://doi.org/10.2807/1560-7917.ES.2018.23.11.17-00042  PMID: 29560856 
  7. Bil JP, Schrooders PAG, Prins M, Kouw PM, Klomp JHE, Scholing M, et al. Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015. Euro Surveill. 2018;23(11):17-00491.  https://doi.org/10.2807/1560-7917.ES.2018.23.11.17-00491  PMID: 29560855 
  8. Mueller-Hermelink M, Kobbe R, Methling B, Rau C, Schulze-Sturm U, Auer I, et al. Universal screening for latent and active tuberculosis (TB) in asylum seeking children, Bochum and Hamburg, Germany, September 2015 to November 2016. Euro Surveill. 2018;23(12):17-00536.  https://doi.org/10.2807/1560-7917.ES.2018.23.12.17-00536 
  9. Greenaway C, Pareek M, Abou Chakra CN, Walji M, Makarenko I, Alabdulkarim B, et al. The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review. Euro Surveill. 2018; (Forthcoming).
  10. Greenaway C, Pareek M, Abou Chakra CN, Walji M, Makarenko I, Alabdulkarim B, et al. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review. Euro Surveill. 2018; (Forthcoming).
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error